A scientist works in the laboratory of PharmaMar laboratory in Colmenar Viejo's area of Madrid. PharmaMar is Spain's principal biopharmaceutical company, and the world's leader in research and development of anti-tumor compounds from marine organisms. (Pedro Armestre/AFP/Getty Images)
More cancer treatments, but do they work?
With nearly 400 cancer drugs in clinical trials, researchers are putting new focus on targeted therapies and shedding old theories on treatment.
Guests
-
Doug Yee: Professor of medicine and pharmacology. He heads the breast cancer program at the University of Minnesota cancer center.
-
Edith Perez: Professor of medicine and director of the breast cancer program at the Mayo Clinic in Jacksonville, Florida. She's also a clinical oncologist.
Resources
